Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Singla, Nirmish
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study	Recruiting	3	100	Europe, US, RoW	padeliporfin VTP, WST11	Steba Biotech S.A., PrimeVigilance, ICON plc	Transitional Cell Cancer of Renal Pelvis and Ureter	12/24	01/29
DISSRM, NCT02346435: The Delayed Intervention and Surveillance for Small Renal Masses () Registry	Recruiting	N/A	600	US		Abramson Cancer Center at Penn Medicine, National Comprehensive Cancer Network	Kidney Neoplasm	01/26	01/26
#HOPE4KIDNEY, NCT05820087: The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy	Recruiting	N/A	68	US	HistoSonics Edison System, Histotripsy	HistoSonics, Inc.	Renal Cancer, Tumor, Solid, Kidney Cancer, Tumor, Tumor, Benign	07/25	05/30